| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | 6O85FK9I0X |
| InChI Key | LNOVHERIIMJMDG-XZXLULOTSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C29H44O3 |
| Molecular Weight | 440.67 |
| AlogP | 7.52 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 1.0 |
| Number of Rotational Bond | 12.0 |
| Polar Surface Area | 54.37 |
| Molecular species | NEUTRAL |
| Aromatic Rings | 0.0 |
| Heavy Atoms | 32.0 |
| Action | Mechanism of Action | Reference |
|---|---|---|
| MODULATOR | Quinone reductase 1) modulator | PubMed |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Mitochondrial Diseases | 2 | D028361 | ClinicalTrials |
| Friedreich Ataxia | 2 | D005621 | ClinicalTrials |
| Child Development Disorders, Pervasive | 2 | D002659 | ClinicalTrials |
| Rett Syndrome | 2 | D015518 | ClinicalTrials |
| Parkinson Disease | 2 | D010300 | ClinicalTrials |
| Hearing Loss, Noise-Induced | 2 | D006317 | ClinicalTrials |
| Leigh Disease | 2 | D007888 | ClinicalTrials |
| Muscular Diseases | 1 | D009135 | ClinicalTrials |
| Tourette Syndrome | 1 | D005879 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL1812161 |
| DrugBank | DB11917 |
| EPA CompTox | DTXSID90153231 |
| FDA SRS | 6O85FK9I0X |
| PubChem | 46184405 |
| SureChEMBL | SCHEMBL503125 |